The Huntington's disease candidate region exhibits many different haplotypes
about
sameAs
Chapter 11: Genome-wide association studiesLinkage disequilibrium in the neurofibromatosis 1 (NF1) region: implications for gene mappingSatellog: a database for the identification and prioritization of satellite repeats in disease association studies.Cloning of the alpha-adducin gene from the Huntington's disease candidate region of chromosome 4 by exon amplificationExpressed genes, Alu repeats and polymorphisms in cosmids sequenced from chromosome 4p16.3Common SNP-based haplotype analysis of the 4p16.3 Huntington disease gene region.Evidence for a modifier of onset age in Huntington disease linked to the HD gene in 4p16.Characterization of a yeast artificial chromosome contig spanning the Huntington's disease gene candidate region.Linkage disequilibrium interval mapping of quantitative trait loci.Whole genome and exome sequencing realignment supports the assignment of KCNJ12, KCNJ17, and KCNJ18 paralogous genes in thyrotoxic periodic paralysis locus: functional characterization of two polymorphic Kir2.6 isoforms.Dynamic mutation in Dutch Huntington's disease patients: increased paternal repeat instability extending to within the normal size range.Significant linkage disequilibrium between the Huntington's disease locus and markers at loci D4S10, D4S95, and D4S111 in Northern Ireland.Analysis of triplet repeats in the huntingtin gene in Japanese families affected with Huntington's disease.Linkage disequilibrium mapping of quantitative-trait Loci by selective genotypingHaplotypes at ATM identify coding-sequence variation and indicate a region of extensive linkage disequilibrium.Neuroprotective and metabolic effects of resveratrol: therapeutic implications for Huntington's disease and other neurodegenerative disorders.Genome screens using linkage disequilibrium tests: optimal marker characteristics and feasibility.Roles of resveratrol and other grape-derived polyphenols in Alzheimer's disease prevention and treatment.Heterogeneity of microsatellite mutations within and between loci, and implications for human demographic historiesFine localization of the torsion dystonia gene (DYT1) on human chromosome 9q34: YAC map and linkage disequilibrium.Obsessive-Compulsive Disorder Symptoms in Huntington's Disease: A Case Report.Different mechanisms underlie DNA instability in Huntington disease and colorectal cancerNew insights into the clinical features, pathogenesis and molecular genetics of Huntington disease.Fine-scale genetic mapping based on linkage disequilibrium: theory and applicationsLikelihood methods for locating disease genes in nonequilibrium populations.Are moment bounds on the recombination fraction between a marker and a disease locus too good to be true? Allelic association mapping revisited for simple genetic diseases in the Finnish populationRefining the position of Wilson disease by linkage disequilibrium with polymorphic microsatellitesHaplotype studies in Wilson diseaseAnonymous marker loci within 400 kb of HLA-A generate haplotypes in linkage disequilibrium with the hemochromatosis gene (HFE)Linkage disequilibrium predicts physical distance in the adenomatous polyposis coli region.Refined mapping of a gene responsible for Fukuyama-type congenital muscular dystrophy: evidence for strong linkage disequilibrium.Linkage disequilibrium in the region of the autosomal dominant polycystic kidney disease gene (PKD1).Allelic association under map error and recombinational heterogeneity: a tale of two sites.Normal and expanded Huntington's disease gene alleles produce distinguishable proteins due to translation across the CAG repeat.Evolution of the Friedreich's ataxia trinucleotide repeat expansion: founder effect and premutations.A cosmid contig and high resolution restriction map of the 2 megabase region containing the Huntington's disease gene.Haplotype analysis of the 4p16.3 region in Portuguese families with Huntington's disease.Trends in the molecular pathogenesis and clinical therapeutics of common neurodegenerative disordersRNA surveillance: molecular approaches in transcript quality control and their implications in clinical diseases.The Relevance of Genomic Signatures at Adhesion GPCR Loci in Humans.
P2860
Q21145310-C3F508FB-D441-41AA-85D4-17F1EF2B86E7Q24671014-1D173333-BE6A-4E05-AC40-6229CF116077Q24815425-96DC16B8-E078-404B-A2D5-DFF513728965Q28118724-32565385-8BFC-479A-AA96-6CD59D4CE762Q28213608-A2383B74-BB43-4EAA-84D2-2AE59B95243BQ30425027-5E36E6C3-9B1D-4693-8538-7B97F570CFD8Q30445013-04D430D9-01E5-4C16-8324-8EC2C7A7E6DFQ31158475-5E7664FE-8019-4084-85AC-D6168CAF59CFQ33236756-AA495BAF-9450-4D37-B3D8-16C908F26186Q33362836-B22E6933-261A-47AF-B39D-CB9519463C25Q33596071-137C64A0-1479-4215-855B-B755B37715EEQ33596099-E1B3B30E-B5EC-4ACA-808D-53FD47B8ED22Q33682442-B0D9FCE2-6962-4876-B0DF-923E821472AFQ34114563-A4DA8782-63B6-42F3-B5B3-F4F4FBFA3862Q34144298-31822258-13E7-49C5-B599-521C7CEE90B5Q34215149-B8FEEAC6-D5C1-4719-9E51-4378DA251CA1Q34388309-217F7DB5-3136-4958-9895-1F637E2A7CA6Q34443537-134C9E75-FD33-43C7-8A32-346D8945AF44Q34603478-67088B55-6F9E-486E-9C8D-BF584B87F828Q34740224-25A646DA-34AB-4D26-A4B6-2DB35014F985Q35016366-D423DE00-6287-4D75-9960-601E619F6CE0Q35238626-672FA921-4363-46E2-A3FC-666FEA44F76CQ35243890-791F6E04-6F70-49BC-9169-1F2B02CF916AQ35250449-CD57AC4A-0F6D-4D35-93E3-5F2910667747Q35643868-2E0BD878-DC7F-4BEA-83BB-DE37306EBA63Q35644114-F2232D43-40C4-4D27-92BA-D99B24A9C5DCQ35888843-F874C8BA-C380-48D5-AE43-C614FBD8CC06Q35888860-7054E1E4-3185-407E-AF1F-AAC6BD761950Q35889091-9520D347-EBEA-452E-BC42-0720D456E9D5Q35889324-FE5AF8EE-67AE-4397-AFC8-FC60608BC7CAQ35889527-FAF4471D-8037-4F96-B42B-14E48F85BDFDQ35889622-3E5D99C5-8668-4A00-B769-4CB63A2977B9Q36310508-1621FA5A-C95D-4EC6-A0C3-0D91EFDD73E1Q36437616-BBC6DD3C-0E25-42D7-9E0B-39490FA25581Q36658216-AC0892B6-F1AD-4AA4-BA0E-4452D1871BCDQ36766598-EC44A74F-574D-425A-881F-DE564C8B42B4Q37221971-E55151B8-1B3F-430A-90BE-7004899DDF7AQ37249765-538E4CEE-5609-4778-A6AE-1FBD5FC06EA0Q37385250-2E77BC00-B64D-4884-BCE1-C7283C718C6DQ39004698-193DB79B-BE05-4AFA-99DC-503D14DDCE22
P2860
The Huntington's disease candidate region exhibits many different haplotypes
description
1992 nî lūn-bûn
@nan
1992 թուականի Մայիսին հրատարակուած գիտական յօդուած
@hyw
1992 թվականի մայիսին հրատարակված գիտական հոդված
@hy
1992年の論文
@ja
1992年論文
@yue
1992年論文
@zh-hant
1992年論文
@zh-hk
1992年論文
@zh-mo
1992年論文
@zh-tw
1992年论文
@wuu
name
The Huntington's disease candidate region exhibits many different haplotypes
@ast
The Huntington's disease candidate region exhibits many different haplotypes
@en
The Huntington's disease candidate region exhibits many different haplotypes
@nl
type
label
The Huntington's disease candidate region exhibits many different haplotypes
@ast
The Huntington's disease candidate region exhibits many different haplotypes
@en
The Huntington's disease candidate region exhibits many different haplotypes
@nl
prefLabel
The Huntington's disease candidate region exhibits many different haplotypes
@ast
The Huntington's disease candidate region exhibits many different haplotypes
@en
The Huntington's disease candidate region exhibits many different haplotypes
@nl
P2093
P2860
P356
P1433
P1476
The Huntington's disease candidate region exhibits many different haplotypes
@en
P2093
A Novelletto
M E MacDonald
P2860
P2888
P304
P356
10.1038/NG0592-99
P407
P577
1992-05-01T00:00:00Z